As of 03 Nov 2026 11:31 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2024/008 (23 Jan 2024): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Lantus® (insulin glargine) Solostar® 100units/ml solution for injection 3ml pre-filled pensaffected product · inferred from phrasing | Limited supply, as stated | to be confirmed, as stated | notice of 23 Jan 2024 |
| Abasaglar® (insulin glargine) KwikPen® 100units/ml solution for injection 3ml pre-filled pensnamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 23 Jan 2024 |
| Lantus® (insulin glargine) 100units/ml solution for injection 10ml vials and 3ml cartridgesnamed by the source as remaining available · inferred from phrasing | Stated as available; cannot support an uplift in demand | — not stated for this line | notice of 23 Jan 2024 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Abasaglar® (insulin glargine) KwikPen® 100units/ml solution for injection 3ml pre-filled pens — named by the source as remaining available (inferred from phrasing)
- Lantus® (insulin glargine) 100units/ml solution for injection 10ml vials and 3ml cartridges — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Lantus
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 23 Jan 2024. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 23 Jan 2024 | Medicine Supply Notification: Lantus® Solostar® (insulin glargine) 100units/ml solution for injection 3ml pre-filled pens | Supply notification | Tier 2 | MSN/2024/008 |
Also recorded under
Bracketed names seen in this medicine's notice titles: insulin glargine. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
No NHS Scotland Medicine Supply Alert Notice on record matches this name. Scotland is a separate record (all Scotland alerts); absence here is not a statement about supply in Scotland.